CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A

CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A, 1, 2025 is a comprehensive biology reference published by Elsevier. Description By Vijay Singh Dr CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A, Volume 208 represents CRISPR-Cas systems for genome editing.

Key Features

- CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A, Volume 208 represents CRISPR-Cas systems for genome editing
- Currently, CRISPR-Cas systems are proven a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution
- CRISPR-Cas9 system is being used in microbial genome editing, mammalian genome editing, disease models, and more
- It has shown potential in human disease treatment
- However, it is not easy to find CRISPR-Cas systems genome editing in a single source.This volume offers CRISPR-Cas systems for human diseases, bacterial disease, gut microbiome…
- In addition, it highlights a number of aspects of the CRISPR-Cas systems that can help the basic understanding of students, researchers, clinicians, entrepreneurs, and…
- Updares on CRISPR-Cas systems for human diseases, bacterial disease, gut microbiome editing, viral disease, protozoan disease and fungal disease

Product Details

Publisher: Elsevier
Edition: 1
Published Year: 2025
Format: EPUB
File Size: 9.2 MB
ISBN: 978-0443315886, 9780443315893